HomeResearch & Resources

ImmunoCeutica Inc is committed to providing

widely researched and publicized information.

RESOURCES

*Cited on Vitamin D page

• * Vitamin D and Ageing
• * Increased Risk of Vitamin D Deficiency Among HIV-Infected Individuals: A Systematic Review and Meta-Analysis 
• Association of Vitamin D Deficiency With Pulmonary Tuberculosis: A Systematic Review and Meta-Analysis
• The Crosstalk between Vitamin D and Pediatric Digestive Disorders
• * Biophysical evidence to support and extend the vitamin D-folate hypothesis as a paradigm for the evolution of human skin pigmentation
• Genetic Determinants of 25-Hydroxyvitamin D Concentrations and Their Relevance to Public Health
• * Immunoceuticals: Harnessing Their Immunomodulatory Potential to Promote Health and Wellness

Cited on “Vitamin D and The Immune System” post

• Murdaca et al. 2019. Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications.
• Urashima et al. 2010. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in school children.
• Gruber-Bzura 2018. Vitamin D and Influenza-Prevention or Therapy?
• Zaman 2010. Tuberculosis: a global health problem.
• Cao et al. 2022. Vitamin D and the risk of latent tuberculosis infection: a systematic review and meta-analysis.
• 18th Century Sanatoria revisited: sunlight and health.
• D’Avolio A et al. 2020. 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2. Nutrients, 12(5), 1359.
• Dror A et al. 2022. Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness.
• Maghbooli Z et al. 2020. Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.
• Castillo et al. 2020. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19.
• Sabico S et al. 2021. Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19
• Murai IH et al. 2021. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19
• Meta-analyses support the use of vitamin D

Factors Influencing Vitamin D Levels

• Tsiaras et al. 2011. Factors influencing vitamin D status.
• Lee et al. 2007. Vitamin D deficiency in a healthy group of mothers and newborn infants.
• Holick et al. 2017b. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention.
• Samefors M et al. 2014. Vitamin D deficiency in elderly people in Swedish nursing homes is associated with increased mortality, European Journal of Endocrinology, 170(5), 667-675.

Vitamin D Toxicity

• Marcinowska-Suchowierska et al. 2018. Vitamin D Toxicity – A Clinical Perspective.
• Tan et al. 2020. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19).

More on Vitamin D

• Vitamin D supplementation and incident dementia Effects of sex APOE (pdf)
• Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes
• Vitamin D supplementation increases objective response rate and prolongs progression-free time in patients with advanced melanoma undergoing anti-PD1 therapy
• Vitamin D Influences the Activity of Mast Cells in Allergic Manifestations and Potentiates Their Effector Functions against Pathogens